STOCK TITAN

Calliditas Therapeutics AB - CALT STOCK NEWS

Welcome to our dedicated news page for Calliditas Therapeutics AB (Ticker: CALT), a resource for investors and traders seeking the latest updates and insights on Calliditas Therapeutics AB.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Calliditas Therapeutics AB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Calliditas Therapeutics AB's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.79%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.79%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.95%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.29%
Tags
partnership clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.23%
Tags
clinical trial
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.06%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.02%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
none
Calliditas Therapeutics AB

Nasdaq:CALT

CALT Rankings

CALT Stock Data

568.77M
37.48M
3.17%
0.03%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Sweden
Stockholm

About CALT

Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.